ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Lorlatinib Tablet shortage

To Be Discontinued  1 presentations · 1 manufacturers · first FDA posting 2026-06-15 · last update 2026-06-15

Manufacturers: Pfizer Inc.

Stated reasons (per FDA): Not stated

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Lorbrena, Tablet, 25 mg; 120 tablets bottle with a child-resistant closure (NDC 0069-0227-03)Pfizer Inc.To Be Discontinued
 —Supply expected to exhaust 6/30/2026; NDC 0069-0227-01 25 mg; 30 tablets bottle with a child-resistant closure will continue to be manufactured; Discontinuation of the manufacture of this presentationPosted 06/15/2026
Updated 06/15/2026
Discontinued 06/15/2026

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)